Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Outsourcing channel feed
Moderna turbocharges its supply chain, upping commitment to 3B doses per year for a future where boosters are likely
5 years ago
Coronavirus
Manufacturing
Evotec strengthens its French connection, pledging to drop $120M into Toulouse plant for Covid-19 antibodies
5 years ago
Manufacturing
Abzena picks North Carolina as the home for its 6th manufacturing site, plans to add 325 jobs in Sanford
5 years ago
Manufacturing
Piramal Pharma Solutions picks up Indian peptide API maker in push into oncology, metabolic contract work
5 years ago
Manufacturing
Merck KGaA adds 350 workers at French site to build capacity for 'single-use' tech for Covid-19 vaccines, therapies
5 years ago
Manufacturing
Ani Pharma picks up generic player for a cool $210M, turbocharging its manufacturing and R&D wings
5 years ago
Manufacturing
Thermo Fisher will drop a whopping $600M into its manufacturing supply chain as Covid-19 work ramps up
5 years ago
Manufacturing
AbbVie offloads UK site for $119M in sale to Chinese cell and gene therapy player Pharmaron
5 years ago
Cell/Gene Tx
Manufacturing
Swiss CDMO Celonic finds a home at Novartis' Stein hub, plans to add 250 new jobs centered on next-gen drugs
5 years ago
Cell/Gene Tx
Manufacturing
A 'love story': WuXi AppTec wraps UK-based CRO into its cell and gene therapy unit
5 years ago
Deals
Manufacturing
Avid Bioservices, with recent IPO and Covid-19 partnership in hand, launches 2nd phase of facility expansion
5 years ago
Manufacturing
Biden wants a review of the API supply chain. Will that parlay into an effort to 'onshore' drug manufacturing?
5 years ago
Manufacturing
Catalent uncorks play in plasmid DNA with buyout of Belgian neighbor Delphi, Maryland expansion launch
5 years ago
Manufacturing
Israeli API maker Wavelength buys up majority stake in Indian firm making drug starting materials and intermediates
5 years ago
Manufacturing
AstraZeneca looks to rebound from production delays for its Covid-19 vaccine with new fill-finish deal
5 years ago
Coronavirus
Manufacturing
Lonza offloads specialty ingredients unit in $4.7B sale to Bain Capital, Cinven in consolidation around biopharma
5 years ago
Manufacturing
Fujifilm's CDMO arm plots massive $2B plant in the US for broad range of therapeutics
5 years ago
Fujifilm's CDMO carves foothold in Boston biotech hub with new HQ focused on viral vectors, gene therapies
5 years ago
Amid a busy year and new leadership, Lonza looks to build bioconjugates capacity with Swiss expansion set for 2022
5 years ago
Manufacturing
Looking to build a 'dual sourcing' supply chain, WuXi Biologics shells out $183M for Bayer drug substance plant
5 years ago
Deals
A booming market propels China CRO to a $100M raise. Is an IPO next?
5 years ago
Financing
China
Continuing rapid expansion, Thermo Fisher says it will add on plasmid DNA manufacturing site in California
5 years ago
Manufacturing
Samsung Biologics promotes new CEO from within to head next phase of rapid manufacturing expansion
5 years ago
People
Thermo Fisher aims to boost its clinical offerings with German expansion — including cold chain for the Covid-19 effort
5 years ago
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page